Neogen Corporation Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount
Neogen Corporation (NEOG) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount of -$1.17 million for the 12-month period ending 2018-05-31, per its 10-K filed 2020-07-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities · last filed 2020-07-30
- Neogen Corporation effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2018 was -$1.17M.
- Neogen Corporation effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2017 was -$1.06M, a 192.48% decline from fiscal 2016.
- Neogen Corporation effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2016 was $1.14M, a 7.12% increase from fiscal 2015.
- Neogen Corporation effective income tax rate reconciliation, deduction, qualified production activity, amount for fiscal 2015 was $1.07M, a 29.96% increase from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount 12 month as first filed |
|---|---|---|
| 2018-05-31 | -$1.17M 10-K · filed 2020-07-30 | $1.17M 10-K · filed 2018-07-27 |
| 2017-05-31 | -$1.06M 10-K · filed 2019-07-30 | $1.06M 10-K · filed 2017-07-28 |
| 2016-05-31 | $1.14M 10-K · filed 2018-07-27 | |
| 2015-05-31 | $1.07M 10-K · filed 2017-07-28 | |
| 2014-05-31 | $821.00K 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |